Filing Flows › Cumberland Pharmaceuticals (CPIX) › Q1 2025
Cumberland Pharmaceuticals (CPIX) Q1 2025 earnings results (first quarter 2025)
10-Q filed May 9, 2025
Cumberland Pharmaceuticals (CPIX) reported revenue of $11.7M for the first quarter 2025 (Q1 2025), +38% from a year earlier and +12% from the quarter before. Operating margin was 11.0%, net earnings $1.3M (10.7% of revenue).
Cumberland Pharmaceuticals, Q1 2025: revenue $11.7M (+38% year over year), operating margin 11.0%, net earnings $1.3M, operating cash flow $3.9M. The chart follows the revenue to costs, profit and cash.
| Q1 2025 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $11.7M | +12% | +38% |
| Operating profit | $1.3M | — | — |
| Net earnings | $1.3M | — | — |
| Operating cash flow | $3.9M | +105% | — |
| Free cash flow | $3.9M | +102% | — |
What changed
Revenue was $11.7M in Q1 2025, up 38% year over year and up 12% from the previous quarter.
Operating profit was $1.3M, a 11.0% margin (up 33.0 points year over year). Total costs grew 1% against revenue growth of 38%. The fastest-growing cost line was Research & development (+12%). Net earnings were $1.3M. The effective tax rate was 0.5%.
Operating cash flow was $3.9M, 312% of net earnings. Non-cash charges added back $1.0M of depreciation and amortization and $74K of share-based compensation. Working capital and other items added $1.5M. Capital expenditures of $48K left free cash flow of $3.9M.
Questions
What was Cumberland Pharmaceuticals' revenue in the first quarter 2025?
Cumberland Pharmaceuticals (CPIX) reported revenue of $11.7M for the first quarter 2025 (Q1 2025), +38% from a year earlier and +12% from the quarter before.
Was Cumberland Pharmaceuticals profitable in the first quarter 2025?
Operating profit was $1.3M (11.0% of revenue) and net earnings $1.3M.